LMLucas Oliveira Maia

Lucas Oliveira Maia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucas Oliveira Maia has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Substance, subject, and setting: A qualitative study of acute inhaled DMT experiences in a structured Brazilian clinical context

    by Sophie Laborde, Marcelo Falchi-Carvalho, Lucas O. Maia, Sam Tullman, Handersson Barros, Geissy Lima-Araujo, Raynara Bolcont, Isabel Wießner, Nicole Galvão-Coelho, Fernanda Palhano-Fontes, et al.

  • Integration of the Psychedelic Experience Among Brazilians: A Survey Study

    by Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia, Everson Meireles, Jaime Andrés Vinasco Barco, Luís Fernando Tófoli

    Psychedelic substances are increasingly studied for their potential contributions to mental health care, particularly due to their capacity to promote profound emotional, cognitive, and behavioral ...

  • Open Access

    The Brazilian Version of the Mystical Orientation Scale Revised (MOSR-BR): An Exploratory Study

    by Ana Cláudia Mesquita Garcia, Everson Meireles, Eliza Mara das Chagas Paiva, Lucas Oliveira Maia, Luís Fernando Tófoli, Leslie J. Francis

    Mystical experiences are commonly described in the context of psychedelic use and other forms of expanded states of consciousness. Although the Mystical Orientation Scale Revised (MOSR) has been used in international studies, no Brazilian Portuguese version had been tested to date. This exploratory study aimed to translate, culturally adapt, and examine the psychometric properties of the MOSR for the Brazilian population (MOSR-BR). The process followed international guidelines, including translation, back-translation, expert committee review, and pre-testing. The final version was applied to a sample of 505 Brazilian adults. Exploratory factor analysis supported a unidimensional structure, explaining 47.6% of the variance. The MOSR-BR showed high internal consistency (α = .95), slightly higher than the original and Italian versions. Construct validity was evidenced by significant positive correlations between MOSR-BR and all subscales of the Death Transcendence Scale, as well as with the Religious and Existential Well-Being subscales of the Spiritual Well-Being Scale. The scale also discriminated between psychedelic substance users and non-users, with higher mystical orientation scores among occasional and frequent users. This exploratory study provides preliminary evidence supporting the value of further research on the MOSR-BR to address acknowledged limitations with the pilot study, including the cross-sectional design, non-causal inferences, recruitment method and participant self-selection, limited generalizability, absence of confirmatory factor analysis and test–retest reliability, and the need for larger and more diverse samples with longitudinal reliability assessment.

  • Open Access

    Ayahuasca, DMT, and Mental Health: A Current Review of Scientific Studies

    by Dráulio B. Araújo, Lucas O. Maia, Tiago Arruda-Sanchez, Nicole Galvão-Coelho, Fernanda Palhano-Fontes

    Purpose of Review: Summarizes preclinical and clinical evidence on ayahuasca—a traditional Amazonian brew combining N , N -Dimethyltryptamine (DMT) and β-carbolines—in treating depression, anxiety, post-traumatic stress disorder, substance use, eating, and personality disorders. Recent Findings: Preclinical work shows enhanced neuroplasticity, reduced inflammation, and oxidative stress. Human neuroimaging reveals decreased default mode network activity, increased functional connectivity and brain entropy, indicating a flexible neural state and modulation of pathways related to neuroplasticity, inflammation, and stress response. Summary: While promising, the evidence is mainly observational. Users report emotional breakthroughs, increased self-awareness, and mystical experiences tied to therapeutic outcomes. Ayahuasca appears to target core psychological and neurobiological processes across disorders but requires caution in psychotic or bipolar individuals and should be administered with support. Randomized trials are needed to confirm efficacy and safety. In structured, culturally sensitive settings, ayahuasca/DMT may offer a novel treatment and, by integrating indigenous wisdom with modern science, deepen our understanding of healing and consciousness.

  • Integrating Holistic Communication into Psychedelic-Assisted Therapies in Hospice and Palliative Care: An Approach Based on Peplau's Theory

    by Ana Cláudia Mesquita Garcia, Felipe Teixeira, Lucas Oliveira Maia

    Psychedelic-assisted therapy (PAT) has shown promising results in alleviating psychological and existential suffering among individuals with serious illnesses. In parallel, nursing offers a robust theoretical framework to guide therapeutic communication in this context. This article explores the application of Peplau's Theory of Interpersonal Relations (PTIR) as a foundation for holistic communication in PAT, particularly in hospice and palliative care. We examine how PTIR's core concepts (person, health, environment, and nursing) along with its articulation of therapeutic roles, phases of the nurse–patient relationship, and the concept of anxiety as a signal of unmet needs, can be integrated into PAT's preparation, dosing, and integration phases. Drawing on a fictional case study involving a patient with advanced cancer, we illustrate how nurses can use PTIR to support emotional processing, foster insight, and promote personal growth during psilocybin-assisted therapy. By aligning Peplau's theory with the emerging field of PAT, this article highlights nursing's vital contribution to the development of safe, ethical, and compassionate psychedelic care practices. The integration of PTIR into PAT provides a valuable model for holistic nursing, offering structured yet flexible guidance for therapeutic communication with patients facing the complex emotional, spiritual, and existential dimensions of life-limiting illness.

  • Validation of the Demoralization Scale for Brazilian cancer patients

    by Milena Schneiders, Vander Monteiro da Conceição, Everson Meireles, Lucas Oliveira Maia, David W. Kissane, Ana Cláudia Mesquita Garcia


  • Death Anxiety Among Users and Non-Users of Psychedelics

    by Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia, Everson Meireles, Denismar Alves Nogueira, Luís Fernando Tófoli

    This study is a survey-type, cross-sectional study conducted in Brazil (n = 517), with online data collection taking place from April to June 2022. The main objective of this study was to evaluate the death anxiety in users and non-users of psychedelics. To this end, we also assessed the validity and reliability of the Death Anxiety Scale in Brazil. The following instruments were used for data collection: a questionnaire for sociodemographic characterization, Death Anxiety Scale, Death Transcendence Scale, and Spiritual Well-Being Scale. Our main results indicated the following: 1) increased death anxiety is associated with never or almost never having used psychedelics; 2) death transcendence, especially creative and religious factors, was the only constant variable in all the explanatory models of the variation in death anxiety; 3) there is a negative relationship between death anxiety and mystical and religious factors of death transcendence. We interpret these results as follows: it's not psychedelics that reduce death anxiety - psychedelics can favor the experience of transcending death. And it's the possibility of transcending death, (idea of continuity beyond physical death, taking both spiritual and symbolic forms) that helps reduce death anxiety. These findings offer valuable insights into the role of psychedelics in human mortality perception.


  • Contributions of the compassionate care approach to psychedelic-assisted therapies in hospice and palliative care

    by Ana Cláudia Mesquita Garcia, Myla Christie Araújo Custódio Bonifácio, Lucas Oliveira Maia


  • Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial

    by Marcelo Falchi-Carvalho, Isabel Wießner, Sérgio Ruschi B. Silva, Lucas O. Maia, Handersson Barros, Sophie Laborde, Flávia Arichelle, Sam Tullman, Natan Silva-Costa, Aline Assunção, et al.


  • Spiritual Well-Being Among Users and Non-Users of Psychedelics: A Cross-Sectional Study

    by Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia, Everson Meireles, Denismar Alves Nogueira, Luís Fernando Tófoli

    This study evaluated the psychometric properties of the Spiritual Well-Being Scale (SWBS) in a Brazilian sample. We analyzed spiritual well-being, defined as existential well-being (EWB) and religious well-being (RWB), among individuals with varying religious and spiritual experiences, both users and non-users of psychedelics. The online cross-sectional survey was conducted in Brazil, from April to June 2022. The psychometric analyses demonstrated reliability and validity based on the internal structure and the relationship with satisfactory external variables concerning the RWB and EWB factors of the SWBS. Validity evidence was shown for both factors (RWB, EWB) with adequate reliability ratings. However, the RWB factor, which was entirely replicated, demonstrated the best group differentiation and internal consistency. Although both factors showed validity, the RWB factor exhibited superior psychometric indices for validity, group discrimination, and reliability. Regarding psychedelics, the association with RWB and EWB demonstrates a U-shaped pattern, as participants who never use these substances typically exhibit higher RWB and EWB indices, succeeded by frequent users. This finding underscores the need for additional studies to further explore the intricate interplay between psychedelics and spiritual well-being.